Search Close


Appointment of Broker

06th September 2010

The Board of Scancell Holdings Plc, (AIM: SCLP), the developer of therapeutic cancer vaccines, announce the appointment of Matrix Corporate Capital LLP as joint broker with immediate effect.

For further information contact:

Professor Lindy Durrant - Scancell Holdings Plc

  • + 44 (0)207 245 1100

John Bick/Kirsty Corcoran - Hansard Communications

  • + 44 (0)207 245 1100

Ross Andrews/Tom Rowley - Zeus Capital - Nominated Adviser/Joint Broker

  • + 44 (0)161 831 1512

Robert Naylor/Stephen Waterman - Matrix Corporate Capital LLP - Joint Broker

  • +44 (0)20 3206 7340

View the full Document

Webcasts, Interviews and Media Coverage

Scancell Holdings lays groundwork for pivotal year

A £3.9mln injection from the life sciences fund Vulpes will effectively bankroll the latest R&D

Tue, 20 Aug 2019 06:05:00

Scancell to begin UK arm of phase II skin cancer trial ‘immediately’

Discussions with US regulators have taken longer than expected, so Scancell will now focus its efforts on completing the UK arm of the trial before re-submitting its US application at a later date

Mon, 19 Aug 2019 06:46:00